Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.760
+0.030 (1.10%)
At close: Apr 2, 2025, 4:00 PM
2.910
+0.150 (5.43%)
After-hours: Apr 2, 2025, 4:32 PM EDT

Anixa Biosciences Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2015 - 2019
Market Capitalization
891139817214349
Upgrade
Market Cap Growth
-35.13%14.71%-42.82%20.19%191.52%-37.33%
Upgrade
Enterprise Value
71917213910640
Upgrade
Last Close Price
2.733.503.165.604.772.06
Upgrade
PS Ratio
-467.53-279.02-
Upgrade
PB Ratio
4.925.964.206.094.115.93
Upgrade
P/TBV Ratio
5.235.634.035.914.035.59
Upgrade
EV/Sales Ratio
-342.38-206.32-
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.01
Upgrade
Asset Turnover
--0.01-0.02-
Upgrade
Quick Ratio
8.638.0411.8914.6028.137.62
Upgrade
Current Ratio
9.358.5512.5014.8328.357.88
Upgrade
Return on Equity (ROE)
-62.61%-60.10%-38.51%-43.74%-61.02%-154.36%
Upgrade
Return on Assets (ROA)
-38.42%-36.70%-24.61%-26.02%-35.92%-81.88%
Upgrade
Return on Capital (ROIC)
-41.78%-40.52%-26.48%-27.34%-37.88%-98.19%
Upgrade
Earnings Yield
-14.20%-11.15%-9.99%-7.92%-9.07%-20.44%
Upgrade
FCF Yield
-9.02%-6.51%-6.32%-3.78%-3.46%-12.63%
Upgrade
Buyback Yield / Dilution
-3.13%-2.96%-1.99%-6.28%-28.57%-12.33%
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q